Needle cap for medical syringe

By designing a needle cap for a medical syringe, inserting a drug vial with its conical distal end and connecting it with the syringe, direct aspiration of the drug is achieved, solving the problems of cumbersome aspiration process and waste of drugs in the prior art. Improves the efficiency and safety of drug aspiration.

CN221932769UActive Publication Date: 2024-11-01BECTON DICKINSON & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202323372211.1
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Priority Date
2022-12-13
Filing Date
2023-12-11
Publication Date
2024-11-01
Estimated Expiration
2033-12-11

AI Technical Summary

Technical Problem

When existing medical syringes aspirate drugs from vials into the syringe, the process is cumbersome and easy to introduce drug administration errors and contamination, and the blunt filling needle cannot completely aspirate the drugs in the vial, resulting in waste of drugs.

Method used

Design a needle cap, which is inserted into the stop of the drug vial through its conical distal end and is coupled to the needle hub of the syringe. The drug is directly suctioned into the syringe through the opening tip of the needle cap, and uses a needle seal to ensure fluid communication and Reduce drug waste.

Benefits of technology

Simplifies the drug aspiration process, reduces drug waste, reduces the risk of drug misuse and contamination, and ensures that all drugs in the vial can be fully aspirated.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221932769U_ABST
    Figure CN221932769U_ABST
Patent Text Reader

Abstract

The title of the utility model is a needle cap for a medical syringe. A needle cap for a medical syringe facilitates the suction of medication into the syringe directly through the injection needle of the syringe through a stop of a medication vial. The proximal end of the needle cap is coupled to the needle hub of the syringe while the outer diameter of the syringe needle is captured within and in sealing engagement with the inner diameter of the needle seal. The open tip tapered distal end of the needle cap is inserted through the stopper of the drug vial. Retraction of the syringe plunger draws medication through the open tip of the needle cap, directly through the syringe needle, into the syringe chamber. After completion of aspiration of the medicament into the syringe, the needle cap is removed and the syringe is ready to inject the medicament to the patient.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure generally relates to a needle cap configured for covering (capping) a medical injection syringe. More specifically, embodiments of the needle cap of the present disclosure facilitate drawing a drug directly from a vial into an injection needle of an injection medical syringe when the needle cap is coupled to the needle hub of the syringe. Background Art

[0002] Liquid drugs and other drugs are usually stored in glass ampoules or vials and sealed with elastomeric stoppers, including - as a non-limiting example - stoppers with or without slit diaphragms. In order to draw the drug contained in the vial into the syringe for subsequent administration to the patient, a cylindrical outer profile blunt filling needle is usually attached to the Luer connector of the syringe to pierce the stopper / diaphragm, and then the syringe plunger is retracted to draw the drug into the syringe chamber. After filling the syringe with the required amount of drug, the blunt filling needle is separated from the syringe and replaced with a hypodermic needle for injection into the patient. Attaching and replacing two different types of needles to the syringe is both cumbersome and time-consuming. Each separate attachment will introduce potential drug administration errors and / or contamination. When the blunt filling needle is separated from the syringe, any remaining drug that is not contained in the syringe cavity and is drawn into the filling needle lumen is wasted. A blunt filling needle with a generally cylindrical profile does not allow for complete aspiration of all of the drug contained within the vial because the flat needle tip cannot maintain contact with residual drug contained within the bottom corners of the vial. Utility Model Content

[0003] Embodiments of the present disclosure relate to a needle cap configured to cover a medical syringe, the needle cap facilitating the drawing of a drug into the syringe through a stopper of a drug vial. When the needle cap is coupled to the needle hub of the syringe, the drug is drawn from the vial directly through the injection needle of the syringe. The proximal end of the needle cap is coupled to the needle hub of the syringe, while the outer diameter of the syringe needle is captured within and sealingly engaged with the inner diameter of the needle seal. The open tip tapered distal end of the needle cap is inserted through the stopper of the drug vial. Retraction of the syringe plunger draws the drug through the open tip of the needle cap, directly through the syringe needle, into the syringe chamber. After the drug is drawn into the syringe, the needle cap is removed, and the syringe is ready to administer the drug to a patient.

[0004] One aspect of the present disclosure relates to a needle cap for a medical syringe. The needle cap includes a tubular body having an inner wall surface defining a cap cavity. The inner wall surface defines an open-ended female Luer tapered profile first cavity portion on the proximal end of the tubular body configured to be selectively coupled to the needle hub of the syringe. The inner wall surface defines an open cap tip on the distal end of the tubular body. A needle seal within the cap cavity divides the cap cavity into a second proximal portion and a third distal portion isolated from each other. The needle seal defines a through hole, which is connected to both the isolated second proximal portion and the third distal portion of the cap cavity. The through hole is in direct fluid communication with the open cap tip without hindrance, and the through hole defines an inner diameter, which is configured to be in mating sealing engagement with the outer diameter of the needle when the syringe needle is captured therein. The tubular body has a tapering truncated cone outer surface profile on its distal end, and the outer surface profile terminates at the open cap tip.

[0005] Another aspect of the present disclosure relates to a syringe with a needle cap. The syringe includes a syringe barrel having a proximal end and a distal end and a syringe cavity therein, and a plunger and a coupled plunger stop in the proximal end of the syringe barrel. A male Luer connector is oriented on the proximal end of the syringe barrel and is in fluid communication with the syringe cavity. A Luer needle hub is coupled to the male Luer connector and is in fluid communication with the syringe cavity. The syringe includes a hollow syringe needle having a proximal end coupled to the Luer needle hub and in fluid communication with the syringe cavity, and a distal open needle tip. The syringe includes a needle cap having a tubular body having an inner wall surface defining a cap cavity therein, the needle cap capturing the distal open needle tip. The inner wall surface of the needle cap defines an open-ended female Luer conical profile first cavity portion on the proximal end of the tubular body coupled to the needle hub. The inner wall surface of the cap also defines an open cap tip on the distal end of the tubular body. The needle seal in the cap cavity divides the cap cavity into a second proximal portion and a third distal portion isolated from each other. The needle seal defines a through hole that communicates with both the isolated second proximal portion and the third distal portion. The through hole has an inner diameter configured to be matingly sealed with the outer diameter of the syringe needle captured therein. The distal opening needle tip is oriented in the third distal portion of the cap cavity and is in direct fluid communication with the opening cap tip without hindrance. The tubular body has a tapering truncated cone-shaped outer surface profile on its distal end, and the outer surface profile terminates at the opening cap tip. BRIEF DESCRIPTION OF THE DRAWINGS

[0006] Exemplary embodiments of the present disclosure are further described in the following detailed description in conjunction with the accompanying drawings, in which:

[0007] Figure 1 is an isometric view of a medical syringe of the present disclosure with a needle cap and a needle shield coupled thereto;

[0008] Figure 2 yes Figure 1 An axial cross-sectional view of a medical syringe with a needle cap and a needle shield attached;

[0009] Figure 3A yes Figure 2 Axial cross-sectional view of needle cap inserted into syringe needle and needle hub;

[0010] Figure 3B is an axial cross-sectional view of an alternative embodiment of a medical syringe with a needle cap and a needle shield coupled to an insertion syringe needle and a needle hub;

[0011] Figure 4 yes Figure 1 An exploded view of a medical syringe, needle cap, and needle shield; and

[0012] Figure 5 yes Figure 1 A view of a needle cap and syringe drawing medication through the stopper of a medication vial.

[0013] To facilitate understanding, identical reference numerals have been used, where possible, to designate identical elements that are common to the figures.The figures are not drawn to scale. DETAILED DESCRIPTION

[0014] The needle cap of a medical syringe facilitates the drawing of the drug into the syringe through the stopper of the drug vial. When the needle cap is connected to the needle hub of the syringe, the drug is drawn directly from the vial through the injection needle of the syringe. The proximal end of the needle cap is connected to the needle hub of the syringe, and the outer diameter of the syringe needle is captured within the inner diameter of the needle seal and is sealed with the inner diameter of the needle seal. The open tip tapered distal end of the needle cap is inserted through the stopper of the drug vial. The retraction of the syringe plunger draws the drug through the open tip of the needle cap, directly through the syringe needle, into the syringe chamber. The needle seal blocks the fluid communication with the proximal portion of the needle cap cavity between the seal and the proximal end of the needle cap, so that the excess drug not drawn into the syringe chamber is not wasted. The tapered distal tip of the needle cap facilitates the complete drawing of the drug from the drug vial. After the drug is drawn into the syringe, the needle cap is removed, and the syringe is ready to administer the drug to the patient.

[0015] Before describing several exemplary embodiments of the present disclosure, it should be understood that the present disclosure is not limited to the details of construction or process steps set forth in the following description. The present disclosure is capable of other embodiments and can be practiced or carried out in various ways.

[0016] In this disclosure, a convention is followed in which the distal end of the device is the end closest to the patient, and the proximal end of the device is the end away from the patient and closest to the practitioner.

[0017] With respect to terms used in this disclosure, the following definitions are provided. As used herein, the use of "a," "an," and "the" includes both the singular and the plural.

[0018] As used herein, the term "Luer connector" refers to a connecting collar that is a standard way to attach syringes, catheters, hub needles, IV tubes, etc. to each other. In some embodiments, the Luer connector includes a Luer slip connector, which includes male and female interlocking tubes (male Luer slip connector and female Luer slip connector) that are slightly tapered so that they can be better held together even with just a simple press / twist fit. The Luer connector can optionally include an additional threaded outer edge to make it more stable. The male end of the Luer connector is typically associated with a flush syringe, and can be interlocked and connected with the female end located on a vascular access device (VAD). The Luer connector also has a distal channel that releasably attaches the Luer connector to the hub of the VAD, and a proximal channel that releasably attaches the Luer connector to the syringe barrel.

[0019] As used herein, ISO 80369-7:2016 defines the specifications of standard Luer connectors, including a 6% taper between the distal end and the proximal end. The male standard Luer connector increases from the open distal end to the proximal end. The female standard Luer connector decreases from the open proximal end to the distal end. According to ISO 80369-7:2016, the outer cross-sectional diameter of the male standard Luer connector measured at 0.75mm from the distal end is between 3.970mm and 4.072mm. The length of the male standard Luer taper is between 7.500mm and 10.500mm. The outer cross-sectional diameter measured at 7.500mm from the distal end is between 4.376mm and 4.476mm. As used herein, the phrases "male standard Luer connector" and "female standard Luer connector" shall refer to connectors with the dimensions described in ISO 80369-7 (which is hereby incorporated by reference in its entirety).

[0020] As will be readily understood by those skilled in the relevant art, although descriptive terms such as "tip", "hub", "thread", "protrusion / insertion", "tab", "ramp", "wall", "top", "side", "bottom", etc. are used throughout the specification to facilitate understanding, they are not intended to limit any components that may be used in combination or alone to implement the various aspects of the embodiments of the present disclosure.

[0021] The matters illustrated in this specification are provided to help fully understand the exemplary embodiments of the present disclosure. Therefore, those of ordinary skill in the art will recognize that various changes and modifications may be made to the embodiments described herein without departing from the scope and spirit of the present disclosure. In addition, for the sake of clarity and brevity, descriptions of well-known functions and configurations are omitted.

[0022] In an exemplary embodiment of the present disclosure, Figure 1 - FIG. 3 depicts a syringe 10. The syringe 10 includes a syringe barrel 12 having a proximal end 14 and a distal end 16. A plunger 18 and a coupled plunger stop 20 are inserted into the proximal end 14 of the syringe barrel 12. A syringe cavity 21 is defined between the distal end 16 of the syringe barrel 12 and the distal end of the plunger stop 20. A male Luer connector 22 on the distal end 16 of the syringe barrel 12 is in fluid communication with the syringe cavity 21. A needle hub 24 is coupled to the male Luer connector 22, which is also in fluid communication with the syringe cavity 21. A hollow syringe needle 26 has a proximal end coupled to the needle hub 24 and a sharp distal open needle tip 28 for subcutaneous puncture of a patient. The distal open needle tip 28 is in fluid communication with the syringe cavity 21 via a cavity defined within the syringe needle 26.

[0023] Reference Figure 2 3, the needle cap 30 has a hollow tubular body 31 having a proximal end 32 incorporating a radially outwardly protruding clamping flange 33. A first inner wall surface 34 of the hollow tubular body 31 defines an open-ended female Luer tapered profile first cavity portion 35. The first inner wall surface 34 is coupled to the outer surface of the needle hub 24 in a mutually sliding fit, frictional engagement manner. In other embodiments, the first inner wall surface defines a female Luer connector, which includes an inner female thread of a threaded Luer connector, which is configured to engage with a corresponding male thread of a threaded Luer hub including a male Luer connector. The inner wall of the hollow tubular body 31 defines a constriction 36 distal to the first inner wall surface 34. The distal end of the constriction 36 within the hollow tubular body 31 has an inner wall surface 38 of reduced diameter, which in turn defines a proximal second portion 39 of the needle cavity and an inwardly protruding radial lip 40. The inner wall of the hollow tubular body 31 distal to the radially protruding lip 40 further defines a seal cavity inner wall 42 and a seal retaining shoulder 44 .

[0024] The annular needle seal 46 is oriented within the seal cavity inner wall 42 between the inwardly protruding radial lip 40 and the seal retaining shoulder 44. The needle seal 46 has an outer diameter surface 48 that is sealingly engaged with the seal cavity inner wall 42. The annular needle seal defines a through hole 50 between its proximal axial end 52 and its distal axial end 54. The through hole 50 receives and captures the syringe needle 26 therein and has an inner diameter surface that is sealingly engaged with the outer surface of the syringe needle. The open needle tip 28 protrudes outwardly from the distal axial end 54 of the needle seal 46 and is in fluid communication with the open distal cap tip 56 of the needle cap 30. The open distal cap tip 56 of the needle cap 30 is in direct, unimpeded fluid communication with the syringe cavity 21 through the needle hub 24 via a fluid flow path from the open needle tip 28 of the syringe needle 26 through the cavity of the syringe needle 26. The needle seal 46 divides the inner cavity of the needle cap 30 into a proximal second portion 39 defined between the proximal axial end 52 of the needle seal 46 and the first cavity portion 35 and a distal third portion 60 defined between the distal axial end 54 of the needle seal 46 and the open distal cap tip 56 of the needle cap. Figure 1-Figure 4 In the syringe embodiment of the present invention, the needle seal 46 is a separate component comprising an elastomeric material. In other embodiments, the needle seal is integrally formed in the needle cap.

[0025] The drug drawn through the open distal cap tip 56 enters only the distal third portion 60 of the needle cap 30 and flows directly through the open needle tip 28 in an unimpeded manner and ultimately into the syringe barrel 12 of the syringe 10. The needle seal 46, which is in sealing engagement with the seal cavity inner wall 42 and the outer diameter of the syringe needle 26, blocks fluid leakage into the proximal second portion 39 and the first cavity portion 35 of the needle cap 30, so that the drawn drug is not trapped and wasted in the needle cap. In some embodiments, the volume of the so-called "dead space" within the third distal portion 60 of the needle cap 30 is minimized to minimize the waste of drawn drug.

[0026] Reference Figure 3A-3B and Figure 4 , the outer exterior surface profile of the needle cap 30 forms a tapered distal end 62 that terminates in an open distal cap tip 56. In other embodiments, the tapered distal end includes other tapered polygonal profiles that terminate in an open distal cap tip. Figure 3BAn alternative embodiment is shown in which the annular needle seal 46 is eliminated and the needle seal is integrally formed within the needle cap 30. In this alternative embodiment, the connection between the needle hub and the needle cap is airtight, thereby eliminating the additional annular needle seal 46 element between the needle cap 30 and the syringe needle 26. The distal open needle tip 28 is positioned proximal to the distal cap tip 56 to avoid accidental needle stick injuries, while also minimizing drug waste during aspiration from a medical container (e.g., a vial). It is expected that any such drug waste will be less than using a separate blunt filling needle to aspirate the drug. Figure 3B As shown, the distal seal end 52 contacts the syringe needle 26 adjacent the open distal needle tip, while the integral annular needle seal 47 is not formed by Figure 3A The separate components shown are provided between the distal seal end 52 and the proximal seal end 54, thereby eliminating Figure 3A The proximal second portion 39 and the distal seal portion 60 in the illustrated embodiment. Figure 3B In some embodiments, the needle seal is integrally formed with the cap, and when the needle is captured therein, the cap forms a mating sealing engagement with the outer diameter of the syringe needle. In other embodiments, the position formed at the interface 37 of the first inner wall surface 34 and the outer surface of the needle hub 24 can be supplemented or replaced by a tight annular seal that is mutually slidingly engaged and frictionally engaged. Figure 3B The annular needle seal 47 and Figure 3A Thus, a tight annular seal at interface 37 will, in some embodiments, eliminate the need for annular needle seal 47 or an additional annular needle seal 46 element. If a tight seal is formed at interface 37, air will not be drawn from this interface, and liquid will not leak at the needle cap-needle hub interface.

[0027] Figure 1 , Figure 2 and Figure 4 30, a selectively removable needle shield 64 is shown coupled to and covering the distal end of the needle cap 30. The needle shield 64 has a proximal open end 66 and a blunt closed tip 68 on its distal end. The needle shield 64 seals the open distal cap tip 56 to prevent foreign matter from entering the needle cap 30 and the syringe 10; its blunt tip 68 also prevents accidental puncture of the sterile syringe packaging, which could occur if the tapered distal end 62 of the syringe was not covered by the needle shield.

[0028] like Figure 5As shown, the tapered distal end 62 of the tip of the needle cap 30 facilitates direct aspiration of the drug from the drug vial 70 while the syringe needle is still in place in the needle cap. The tapered distal end 62 of the needle cap 30 pierces the septum 72 of the drug vial 70 and reaches the vial bottom 74 to directly aspirate the drug 76 or other medical liquids such as water for injection or saline flushing solution into the syringe 10. The tapered distal end 62 of the needle cap 30 allows its open cap tip 56 to extract all of the drug from the vial bottom 74. The smooth tapered distal end 62 of the needle cap 30 reduces the potential penetration of damaged vial septum 72 particles, which may contaminate the drug 76 if the sharp syringe needle tip is used directly to aspirate the drug from the vial 70. Beneficially, when the needle cap 30 covers the syringe needle, it also protects the syringe needle from bending or preventing needle tip flash contact injuries. After the desired amount of drug is drawn into the syringe chamber, the doctor removes the needle cap 30 to expose the injection needle for subsequent injection into the patient. Since the needle and needle hub remain attached to the syringe during the drug drawing into the syringe, handling of the exposed, sharp injection needle is minimized.

[0029] In contrast, without the benefit of using the needle cap 30 of the present disclosure, a medical practitioner performing a patient medication administration regimen would need to attach a blunt filling needle to a bare syringe Luer connector - either by first removing its associated injection needle or by using a syringe without an injection needle. After the blunt filling needle is attached, the medical practitioner draws the medication from the vial into the syringe chamber, then replaces the blunt filling needle with the injection needle in order to administer the medication to the patient. Using a separate, known blunt filling needle instead of the needle cap 30 of the present disclosure requires an additional syringe preparation step, thereby increasing the possibility of administration errors and potential sterility compromise.

[0030] The syringe and syringe needle cap embodiments disclosed herein are constructed of medical grade materials known to those skilled in the art. In some embodiments, the barrel, plunger and shaft described are made of polypropylene and polycarbonate polymers, but are not limited thereto. In some embodiments, the seal is made of an elastomer, such as, for example, a cross-linked rubber, a thermoplastic elastomer, or a fiber-filled polytetrafluoroethylene (PTFE) polymer. In some embodiments, the stopper is made of a polyisoprene polymer or other known elastomers such as butyl rubber, a thermoplastic elastomer, or a thermoplastic vulcanizate.

[0031] References throughout this specification to "one embodiment," "certain embodiments," "various embodiments," "one or more embodiments," or "an embodiment" mean that the specific features, structures, materials, or characteristics described in conjunction with the embodiment are included in at least one embodiment of the present disclosure. Therefore, the appearance of phrases such as "in one or more embodiments," "in certain embodiments," "in various embodiments," "in an embodiment," or "in an embodiment" at various locations throughout this specification does not necessarily refer to the same embodiment of the present disclosure. Furthermore, in one or more embodiments, the specific features, structures, materials, or characteristics may be combined in any suitable manner.

[0032] Although the disclosure herein provides a description with reference to specific embodiments, it should be understood that these embodiments are merely illustrations of the principles and applications of the present disclosure. It will be apparent to those skilled in the art that various modifications and variations may be made to the present disclosure without departing from the spirit and scope of the present disclosure. Therefore, the present disclosure is intended to include modifications and variations within the scope of the appended claims and their equivalents.

Claims

1. A needle cap for a medical syringe, characterized in that: The needle cap comprises: a tubular body having an inner wall surface defining a cap lumen therein, the inner wall surface further defining an open ended female Luer tapered profile first lumen portion on a proximal end of the tubular body, the open ended female Luer tapered profile first lumen portion being configured to selectively couple to a needle hub of a syringe, and the inner wall surface defining an open cap tip on a distal end of the tubular body; a needle seal within the cap cavity, the needle seal dividing the cap cavity into a second proximal portion and a third distal portion isolated from each other, the needle seal defining a through hole communicating with both the second proximal portion and the third distal portion of the cap cavity, the through hole being in direct and unimpeded fluid communication with the open cap tip, and the through hole having an inner diameter configured to matingly sealably engage with an outer diameter of a syringe needle when the needle is captured therein; and The tubular body has a tapered frusto-conical outer surface profile on its distal end, the tapered frusto-conical outer surface profile terminating in the open cap tip.

2. The needle cap according to claim 1, characterized in that: The inner wall surface of the tubular body defines a radially inwardly directed lip adjacent a proximal axial end of the needle seal and a retaining shoulder adjacent a distal axial end of the needle seal.

3. The needle cap according to claim 2, characterized in that: A separate elastomeric needle seal is further included.

4. The needle cap according to claim 1, characterized in that: Wherein the needle seal is integrally formed with the cap and forms a mating sealing engagement with an outer diameter of a syringe needle when the needle is captured therein.

5. The needle cap according to claim 2, characterized in that: The tubular body defines a reduced diameter constriction intermediate its female Luer tapered profile first lumen portion and the tapered frusto-conical distal end, with the needle seal oriented distal to the constriction.

6. The needle cap according to claim 1, characterized in that: The tubular body defines a reduced diameter constriction intermediate its female Luer tapered profile first lumen portion and the tapered frusto-conical distal end, with the needle seal oriented distal to the constriction.

7. The needle cap according to claim 1, characterized in that: The proximal end of the tubular body defines an outwardly projecting clamping flange.

8. The needle cap according to claim 1, characterized in that: The inner wall surface defining the first cavity portion of the cap cavity further includes a female Luer slip connector.

9. The needle cap according to claim 1, characterized in that: The inner wall surface defining the first cavity portion of the cap cavity further includes a female Luer connector.

10. The needle cap according to claim 1, characterized in that: Further included is an elastomeric needle seal.

11. The needle cap according to claim 1, characterized in that: Further included is a needle shield coupled to the distal end of the tubular body and sealing the open cap tip.

12. A syringe, characterized in that: The syringe comprises: a syringe barrel having a proximal end and a distal end and a syringe lumen therein; a plunger and a coupled plunger stop in a proximal end of said syringe barrel; a male Luer connector on the proximal end of the syringe barrel in fluid communication with the syringe lumen; a Luer needle hub coupled to the male Luer connector and in fluid communication with the syringe chamber; a hollow syringe needle having a proximal end coupled to the Luer hub, in fluid communication with the syringe lumen, and a distal open needle tip; a needle cap having a tubular body with an inner wall surface defining a cap lumen therein, the needle cap capturing the distal open needle tip, the inner wall surface further defining an open-ended female Luer-cone profile first lumen portion on a proximal end of the tubular body coupled to the needle hub, and the inner wall surface defining an open cap tip on a distal end of the tubular body; a needle seal within the cap cavity, the needle seal dividing the cap cavity into a second proximal portion and a third distal portion isolated from each other, the needle seal defining a through hole communicating with both the second proximal portion and the third distal portion, the through hole having an inner diameter configured to matingly sealably engage with an outer diameter of the syringe needle captured therein; said distal open needle tip being oriented within said third distal portion of said cap interior cavity in direct and unimpeded fluid communication with said open cap tip; and The tubular body has a tapered frusto-conical outer surface profile on its distal end, the tapered frusto-conical outer surface profile terminating in the open cap tip.

13. The syringe according to claim 12, characterized in that The inner wall surface of the tubular body defines a radially inwardly projecting lip adjacent a proximal axial end of the needle seal, and a retaining shoulder adjacent a distal axial end of the needle seal.

14. The syringe according to claim 13, characterized in that Further included is an elastomeric needle seal.

15. The syringe according to claim 13, characterized in that The tubular body defines a reduced diameter constriction intermediate its female Luer tapered profile lumen portion and a tapered frusto-conical distal end, with the needle seal oriented distal to the constriction.

16. The syringe according to claim 12, characterized in that The tubular body defines a reduced diameter constriction intermediate its female Luer tapered profile lumen portion and a tapered frusto-conical distal end, with the needle seal oriented distal to the constriction.

17. The syringe according to claim 12, characterized in that The proximal end of the tubular body defines an outwardly projecting clamping flange.

18. The syringe according to claim 12, characterized in that The inner wall surface defining the first cavity portion of the cap interior cavity further includes a female Luer slip connector that mates with a corresponding male Luer slip connector of the needle hub.

19. The syringe according to claim 12, characterized in that The inner wall surface defining the first cavity portion of the cap cavity further includes a female Luer connector that mates with a corresponding male Luer connector of the needle hub.

20. The syringe according to claim 12, characterized in that Further included is a needle shield coupled to the distal end of the tubular body and sealing the open cap tip.